company

VETPHARMA AS

1395 HVALSTAD

Return on Equity
43,02 %
Current Ratio
1,95
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue20 730 000
Net Income8 981 000
Total Assets31 272 000
Total Equity20 876 000
Income (NOK)2022
Revenue20 730 000
Expenditure16 168 000
Operating Profit4 563 000
Financial Income6 351 000
Financial Costs1 050 000
Financial Balance5 301 000
Earnings Before Tax9 864 000
Tax883 000
Net Income8 981 000
Balance (NOK)2022
Total Fixed Assets10 986 000
Total Current Assets20 286 000
Total Assets31 272 000
Total Retained Equity16 726 000
Total Equity20 876 000
Total Long-Term Debt0
Total Current Debt10 396 000
Total Equity and Debt31 272 000
Cash flow (NOK)2022
Sales Income20 730 000
Other Income0
Revenue20 730 000
Cost of Goods Sold12 667 000
Salary Costs1 121 000
Depreciation260 000
Impairment0
Expenditure16 168 000
Operating Profit4 563 000
Financial Income6 351 000
Financial Costs1 050 000
Financial Balance5 301 000
Dividends6 450 000
Net Income8 981 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets2 076 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets8 909 000
Total Fixed Assets10 986 000
Stock4 946 000
Total Investments2 318 000
Cash, Bank8 468 000
Total Current Assets20 286 000
Total Assets31 272 000
Total Equity20 876 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors2 269 000
Unpaid Taxes674 000
Dividends6 450 000
Other Current Debt121 000
Total Current Debt10 396 000
Total Equity and Debt31 272 000
Financial indicators2022
Return on Equity43,02 %
Debt-to-Equity Ratio0
Operating Profit Margin22,01 %
Current Ratio1,95
Quick Ratio3,72
Equity Ratio0,67
Gross Profit Margin38,9 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English